Cellectar Biosciences Inc

NASDAQ CLRB

Data sourced from iex and EODHD
Download Data

Cellectar Biosciences Inc Income Statement 2005 - 2023

This table shows the Income Statement for Cellectar Biosciences Inc going from 2005 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31 2007-12-31 2006-12-31 2005-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0
Cost of Revenue
M 0 0 0 0 - 0 0 0 0 0 0 0 0 - - - - - -
Gross Profit
M 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 - 0 0
Operating Expenses
M 39 29 24 15 - 13 14 9 9 10 12 9 7 5 10 17 - 9 5
Selling, General, and Administrative Expenses (SG&A)
M 11 10 7 5 5 5 4 5 3 4 4 4 3 2 2 2 3 2 1
Research and Development (R&D) Expenses
M 28 19 18 10 9 7 9 5 5 6 7 5 4 3 8 15 17 6 1
Other Operating Expenses
M 0 0 0 0 - 2 0 0 0 0 1 0 1 0 0 0 - 0 3
Costs and Expenses
M 39 29 24 15 - 12 14 9 9 10 11 9 6 - - - - - -
Operating Income
M -39 -29 -24 -15 -14 -13 -14 -9 -9 -10 -12 -9 -7 -5 -10 -17 -20 -9 -5
Interest Expense
M - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 1 0 0 0 0 -2 0 3 3 2 1 0 -1 8 -12 0 0 0 0
EBT
M -38 -29 -24 -15 -14 -13 -14 -6 -5 -8 -11 -9 -8 -13 -26 -23 -30 -9 -3
Income Tax Provision
M 0 0 0 0 0 -2 0 -3 -3 -2 -1 0 1 -8 12 0 -1 -1 0
Income after Tax
M -38 -29 -24 -15 -14 -12 -14 -3 -2 -7 -10 -9 -9 -5 -38 -23 -29 -8 -4
Non-Controlling Interest
M - 0 0 0 0 2 1 3 0 0 0 - - - - - - - -
Net Income
M - -29 -24 -15 -14 -15 -15 -9 -5 -8 -11 - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 12,221,571.00 7,055,665.00 5,551,572.00 1,981,265.00 767,509.00 296,197.00 140,313.00 43,666.00 7,819.00 4,592.00 2,794.00 2,056.00 1,197.00 147.00 22.00 14.00 12.00 12.00 12.00
EBITDA
M -39 -29 -24 -15 -14 -10 -12 -12 -12 -11 -11 -8 -5 -13 2 -17 -20 -9 -2
Depreciation and Amortization
M 0 0 0 0 0 0 2 0 0 0 0 0 1 0 0 0 0 0 0
EBIT
M -39 -29 -24 -15 -14 -10 -14 -13 -12 -12 -12 -9 -6 -13 2 -17 -20 -9 -2
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.16 0.21 0.63 2.24 1.55 11.74 0.29 52.90 62.27 19.28 4.85 -0.11 -14.76 59.64 -46.06 0.61 2.48 7.53 -15.39
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0 0 0 0 0 0 0 - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - 100.00 100.00 100.00 100.00 - 100.00 100.00
Operating Income Margin
% - - - - - - - - - - - - 63,979.27 -16,351.72 -10,555.25 -13,170.82 - -70,961.60 -40,428.32
Net Income Margin
% - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - 45,388.96 -38,876.20 2,049.87 -13,164.56 - -70,933.66 -16,968.75
EBIT Ratio
% - - - - - - - - - - - - 50,705.70 -38,982.23 2,016.28 -13,177.96 - -71,009.28 -16,994.52
EBT Ratio
% - - - - - - - - - - - - 70,469.15 -37,960.15 -27,289.52 -18,227.50 - -67,920.98 -25,146.86

StockViz Staff

September 20, 2024

Any question? Send us an email